Related Experiment Video
Updated: Jan 14, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
CLIC6's role in cancer: from broad analysis to breast cancer validation
Junyi Wang1, Yiyang Wang1, Haotian Ma1
1Department of Breast Surgery, Center of Digestive and Vascular, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Background:
Chloride Intracellular Channel 6 (CLIC6) is a potential cancer therapy target due to its close association with tumor development. However, its diagnostic and prognostic roles, as well as its impact on immune regulation in different cancers, remain unclear.
Methods:
This study utilized public databases like TCGA and GEO to analyze CLIC6 expression, diagnostic value, and prognostic significance across various cancers. It examined genetic and epigenetic variations, immune correlations, and performed functional enrichment analysis to uncover CLIC6-related pathways. Western blotting confirmed CLIC6 protein levels in breast cancer samples, while CCK-8, colony formation, transwell, and scratch assays evaluated its role in cell proliferation and migration. Tissue microarray and immunohistochemistry further validated CLIC6 expression in breast cancer.
Results:
Research shows that CLIC6 expression is typically lower in most cancers compared to normal tissues, with distinct patterns across different stages. It serves as a useful diagnostic marker and potential prognostic factor for BRCA, LUAD, STAD, and LGG. CLIC6 mutations are common in many cancers and affect prognosis. In most tumors, CLIC6 expression correlates with m6A methylation, and its promoter is highly methylated. In BRCA, the expression of CLIC6 is related to bacterial defense, immune response, endopeptidase regulation, neuropeptide signaling, and amino acid transport. It is expressed at low levels in BRCA tissues, and we speculate that a higher CLIC6 expression may be protective.
Conclusion:
In conclusion, CLIC6 can serve as a key biomarker for various cancers, and its expression level is related to the tumor immune microenvironment and the outcomes in selected cancers; further validation is warranted. Our research on CLIC6 in BRCA has revealed new potential for tumor treatment strategies targeting this marker.
More Related Videos
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Positive Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

